Cantel Medical (CMN) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Piper Jaffray Raises Price Target on Cantel Medical (CMN) Following 3Q15
June 10, 2015 8:21 AM EDTPiper Jaffray reiterates an Overweight rating on Cantel Medical (NYSE: CMN), and raised the price target to $60.00 (from $49.00), following 3Q15. CMN reported sales of $141.5M, which was $5.5M above forecast. Earnings were $0.35, 2 cents above estimates.
Analyst Thomas Gunderson commented, "Strong sales growth of 18% was led by the Endoscopy (up 35%) and Water Purification... More
